Vivienne Frances Cox

Title: Vivienne Frances Cox: Innovator in Molecular Biology

Introduction

Vivienne Frances Cox is a prominent inventor based in Herts, GB. She has made significant contributions to the field of molecular biology, particularly in the development of innovative solutions for complement inhibitors and immune response enhancement.

Latest Patents

Cox holds 2 patents that showcase her expertise. Her latest patents include the invention of complement receptor type 1 (CR1)-like sequences. This invention involves the replacement of codons in DNA encoding the first three short consensus repeats (SCRs) of long homologous repeat A (LHR-A) of CR1. This modification can lead to the creation of chimeric genes that express active complement inhibitors with functional complement inhibitory properties, including anti-haemolytic activity. Additionally, she has developed a method involving non-identical genes and their application in improved molecular adjuvants. This invention provides a linear concatamer of at least two non-identical DNA sequences that encode the same polypeptide, which can be utilized in pharmaceutical compositions such as DNA vaccines.

Career Highlights

Cox is associated with Adprotech Limited, where she continues to advance her research and innovations. Her work has been instrumental in the development of new therapeutic approaches in immunology.

Collaborations

Some of her notable coworkers include Richard Anthony Godwin Smith and Pamela Jane Elizabeth Rowling. Their collaborative efforts contribute to the innovative environment at Adprotech Limited.

Conclusion

Vivienne Frances Cox is a trailblazer in molecular biology, with her patents reflecting her commitment to advancing medical science. Her work continues to inspire future innovations in the field.